Quang X. Pham was appointed Chairman & CEO of Cadrenal Therapeutics, Inc. on August 11, 2025.
3 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Quang X. Pham was appointed Chairman & CEO of Cadrenal Therapeutics, Inc. on August 11, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Cadrenal aligned with the FDA on its Phase 3 clinical trial pathway.1 source
Quang X. Pham takes leadership role at Cadrenal Therapeutics.1 source
Keep exploring
The entities involved
-
Quang X. Pham
American politician
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- Business WireCadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update Announces strategic clinical trial plans for tecarfarin in patients with End-Stage Kidney Disease (ES
- Business WireCadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-Stage Kidney Disease (ESKD) Transitioning to Dialysis Advances knowledge about the use of tecarfari